Serial evaluation of lipid profiles and risk factors for development of hyperlipidemia after cardiac transplantation.

[1]  M. Hess,et al.  Accelerated coronary atherosclerosis in cardiac transplantation. , 1991, Cardiovascular clinics.

[2]  D. Fitchett,et al.  Dyslipoproteinemias after heart and heart-lung transplantation: potential relation to accelerated graft arteriosclerosis. , 1989, The Journal of heart transplantation.

[3]  A. Gotto,et al.  Effects of cyclosporine therapy on plasma lipoprotein levels. , 1989, JAMA.

[4]  C. V. van Buren,et al.  LIPID ABNORMALITIES IN CYCLOSPORINE‐PREDNISONE‐TREATED RENAL TRANSPLANT RECIPIENTS , 1989, Transplantation.

[5]  A. Menkis,et al.  Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. , 1989, The American journal of cardiology.

[6]  D. Renlund,et al.  Hypercholesterolemia after heart transplantation: amelioration by corticosteroid-free maintenance immunosuppression. , 1989, The Journal of heart transplantation.

[7]  J. Stamler,et al.  Frequency of hypercholesterolemia after cardiac transplantation. , 1988, The American journal of cardiology.

[8]  S. Hunt,et al.  Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. , 1988, The American journal of cardiology.

[9]  D. Renlund,et al.  Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. , 1988, The American journal of medicine.

[10]  J F Silverman,et al.  Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. , 1988, Journal of the American College of Cardiology.

[11]  L. Simons,et al.  Hyperlipidemia after heart transplantation. , 1988, The Journal of heart transplantation.

[12]  A. Gotto,et al.  Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin). , 1987, Transplantation proceedings.

[13]  P S Reddy,et al.  Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. , 1987, Circulation.

[14]  A. Goldberg,et al.  Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. , 1987, The American journal of medicine.

[15]  J. Chapman,et al.  Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression. , 1987, Transplantation proceedings.

[16]  J. Billings,et al.  Cyclosporine improves psoriasis in a double-blind study. , 1986, JAMA.

[17]  R L Blum,et al.  Computer-assisted design of studies using routine clinical data. Analyzing the association of prednisone and cholesterol. , 1986, Annals of internal medicine.

[18]  T. Mohanakumar,et al.  Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia. , 1983, Circulation.

[19]  E. Shafrir,et al.  Origin and pattern of glucocorticoid-induced hyperlipidemia in rats. Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity. , 1981, Biochimica et biophysica acta.

[20]  D. Alonso,et al.  Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. , 1977, The American journal of pathology.

[21]  J. Bagdade,et al.  Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat. , 1976, Metabolism: clinical and experimental.

[22]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.